CVS Health Corporation
MX ˙ BMV ˙ US1266501006
SecurityMX:CVS / CVS Health Corporation
InstitutionStephens Consulting, LLC
Latest Disclosed Ownership50 shares
Latest Disclosed Value $ 3,968
Stephens Consulting, LLC ownership in CVS / CVS Health Corporation

On January 13, 2026 - Stephens Consulting, LLC filed a 13F-HR form disclosing ownership of 50 shares of CVS Health Corporation (MX:CVS) valued at $3,968 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 15, 2025 disclosing 50 shares of CVS Health Corporation. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-13 2025-12-31 13F CVS HEALTH COM 126650100 50 0 0.00 4 0.00 0.0013
2025-10-15 2025-09-30 13F CVS HEALTH COM 126650100 50 -39 -43.82 4 -50.00 0.0013
2025-07-25 2025-06-30 13F CVS HEALTH COM 126650100 89 -66 -42.58 6 -40.00 0.0015
2025-04-17 2025-03-31 13F CVS HEALTH COM 126650100 155 0 0.00 11 66.67 0.0026
2025-01-27 2024-12-31 13F CVS HEALTH COM 126650100 155 -164 -51.41 7 -70.00 0.0017
2024-10-18 2024-09-30 13F CVS HEALTH COM 126650100 319 -295 -48.05 20 -44.44 0.0051
2024-07-29 2024-06-30 13F CVS HEALTH COM 126650100 614 -253 -29.18 36 -47.83 0.0103
2024-04-17 2024-03-31 13F CVS HEALTH COM 126650100 867 -201 -18.82 69 -17.86 0.0212
2024-02-01 2023-12-31 13F CVS HEALTH COM 126650100 1,068 -4 -0.37 84 13.51 0.0286
2023-10-25 2023-09-30 13F CVS HEALTH COM 126650100 1,072 2 0.19 75 1.37 0.0304
2023-07-21 2023-06-30 13F CVS HEALTH COM 126650100 1,070 -78 -6.79 74 -14.12 0.0293
2023-04-19 2023-03-31 13F CVS HEALTH COM 126650100 1,148 -200 -14.84 85 -32.00 0.0514
2023-01-20 2022-12-31 13F CVS HEALTH COM 126650100 1,348 0 0.00 126 -2.34 0.0834
2023-01-20 2022-09-30 13F CVS HEALTH COM 126650100 1,348 2 0.15 129 3.23 0.1155
2023-01-20 2022-06-30 13F CVS HEALTH COM 126650100 1,346 2 0.15 125 -8.82 0.1015
2023-01-20 2022-03-31 13F CVS HEALTH COM 126650100 1,344 -12 -0.88 136 -2.16 0.1113
2023-01-20 2021-12-31 13F CVS HEALTH COM 126650100 1,356 1,356 140 0.1158
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.